At intersection of integrated technology, Arsenalbio raises $85M in a series A financing Oct. 18, 2019 By Lee Landenberger No Comments It was at the constantly changing intersection of data science that Arsenal Biosciences Inc.'s CEO, Ken Drazan, found himself as he helped bring the company to life and to its $85 million series A fundraising.Read More